Relationships Between Recent Intraplaque Hemorrhage and Stroke Risk Factors in Patients With Carotid Stenosis: The HIRISC Study

Objective—Intraplaque hemorrhage (IPH) is an emerging marker of plaque instability. However, little is known about the relationships between IPH and traditional risk factors and whether these relationships differ between symptomatic and asymptomatic disease. Methods and Results—Two hundred thirty-four patients with symptomatic (n=114) or asymptomatic (n=120) carotid stenosis underwent high-resolution plaque magnetic resonance imaging. Seventy-five patients had recent IPH (symptomatic, 33%; asymptomatic, 31%). In symptomatic stenosis, recent IPH was independently associated with degree of stenosis (odds ratio [OR]=4.21, 1.61–10.98 for North American Symptomatic Carotid Endarterectomy Trial >35%; OR=2.92, 1.18–7.24 for European Carotid Surgery Trial >60%), qualifying event (OR=4.13; 1.11–15.32 for stroke or hemispheric transient ischemic attack ≥1 hour versus transient ischemic attack <1 hour or ocular symptoms), time from ischemic event (OR=6.65, 1.56–28.35 for ⩽2 weeks; OR=2.24, 0.87–5.81 for 2–12 weeks versus >12 weeks; P for trend=0.03). In asymptomatic stenosis, IPH was only associated with stenosis severity >70% by ECST (OR=6.65; 1.95–22.73) but not by the NASCET method. Conclusion—Our findings support the potential link between recent IPH and risk of ipsilateral stroke in symptomatic disease but also imply that prognostic studies should adjust for known stroke risk factors in multivariate analyses. In asymptomatic stenosis, the potential predictive value of recent IPH is less likely to be confounded by stroke risk factors.

[1]  Jean-Baptiste Michel,et al.  Intraplaque haemorrhages as the trigger of plaque vulnerability , 2011, European heart journal.

[2]  J. Gladman,et al.  Plaque hemorrhage is a marker of thromboembolic activity in patients with symptomatic carotid disease. , 2011, Radiology.

[3]  C. Yuan,et al.  Sex Differences in Patients With Asymptomatic Carotid Atherosclerotic Plaque: In Vivo 3.0-T Magnetic Resonance Study , 2010, Stroke.

[4]  J. V. van Engelshoven,et al.  Symptomatic Patients With Mild and Moderate Carotid Stenosis: Plaque Features at MRI and Association With Cardiovascular Risk Factors and Statin Use , 2010, Stroke.

[5]  Wouter Peeters,et al.  Composition of Carotid Atherosclerotic Plaque Is Associated With Cardiovascular Outcome: A Prognostic Study , 2010, Circulation.

[6]  Robert A Hegele,et al.  Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis. , 2010, Archives of neurology.

[7]  D. Gladstone,et al.  Moderate carotid artery stenosis: MR imaging-depicted intraplaque hemorrhage predicts risk of cerebrovascular ischemic events in asymptomatic men. , 2009, Radiology.

[8]  C.J.H. Mann,et al.  Clinical Prediction Models: A Practical Approach to Development, Validation and Updating , 2009 .

[9]  Jonathan H Gillard,et al.  Carotid-artery imaging in the diagnosis and management of patients at risk of stroke , 2009, The Lancet Neurology.

[10]  Dorothee Auer,et al.  Detection of intraplaque hemorrhage by magnetic resonance imaging in symptomatic patients with mild to moderate carotid stenosis predicts recurrent neurological events. , 2008, Journal of vascular surgery.

[11]  O. Wagner,et al.  Progression of Carotid Stenosis Detected by Duplex Ultrasonography Predicts Adverse Outcomes in Cardiovascular High-Risk Patients , 2007, Stroke.

[12]  L. Jiao,et al.  Correlation Between Carotid Intraplaque Hemorrhage and Clinical Symptoms: Systematic Review of Observational Studies , 2007, Stroke.

[13]  Catherine Oppenheim,et al.  Reproducibility of High-Resolution MRI for the Identification and the Quantification of Carotid Atherosclerotic Plaque Components: Consequences for Prognosis Studies and Therapeutic Trials , 2007, Stroke.

[14]  C. Levi,et al.  What Should We Do with Asymptomatic Carotid Stenosis? , 2007, International journal of stroke : official journal of the International Stroke Society.

[15]  Renu Virmani,et al.  Histopathology of Carotid Atherosclerotic Disease , 2006, Neurosurgery.

[16]  P J Gallagher,et al.  Histological Assessment of 526 Symptomatic Carotid Plaques in Relation to the Nature and Timing of Ischemic Symptoms: The Oxford Plaque Study , 2006, Circulation.

[17]  A. Nicolaides,et al.  Severity of asymptomatic carotid stenosis and risk of ipsilateral hemispheric ischaemic events: results from the ACSRS study. Nicolaides et al.: EJVES 2005; 30: 275-284. , 2006, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[18]  Chun Yuan,et al.  Association Between Carotid Plaque Characteristics and Subsequent Ischemic Cerebrovascular Events: A Prospective Assessment With MRI—Initial Results , 2006, Stroke.

[19]  A. Nicolaides,et al.  Severity of asymptomatic carotid stenosis and risk of ipsilateral hemispheric ischaemic events: results from the ACSRS study. , 2005, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[20]  G. Hamilton,et al.  The retrojugular approach to carotid endarterectomy--a safer technique? , 2005, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[21]  Chun Yuan,et al.  Presence of Intraplaque Hemorrhage Stimulates Progression of Carotid Atherosclerotic Plaques: A High-Resolution Magnetic Resonance Imaging Study , 2005, Circulation.

[22]  C. Yuan,et al.  Quantitative Evaluation of Carotid Plaque Composition by In Vivo MRI , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[23]  on behalf of the Acst Collaborative Group ACST Writing Committee.  ACST: which subgroups will benefit most from carotid endarterectomy? , 2004, The Lancet.

[24]  L. Hofstra,et al.  ACST: which subgroups will benefit most from carotid endarterectomy? , 2004, The Lancet.

[25]  P. Rothwell.  ACST: which subgroups will benefit most from carotid endarterectomy? , 2004, The Lancet.

[26]  R. Peto,et al.  Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial , 2004, The Lancet.

[27]  Chun Yuan,et al.  Hemorrhage in the Atherosclerotic Carotid Plaque: A High-Resolution MRI Study , 2004, Stroke.

[28]  M. Eliasziw,et al.  Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery , 2004, The Lancet.

[29]  E. Boerwinkle,et al.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. , 2003, Circulation.

[30]  S. Gutnikov,et al.  Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis , 2003, The Lancet.

[31]  M. Davies,et al.  Relationship Between Coronary Artery Remodeling and Plaque Vulnerability , 2002, Circulation.

[32]  C. Warlow,et al.  Prediction of benefit from carotid endar terectomy in individual patients: a risk-modelling study , 1999, The Lancet.

[33]  J. Concato,et al.  Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. , 1995, Journal of clinical epidemiology.

[34]  A. Davies,et al.  Endarterectomy for asymptomatic carotid artery stenosis , 1995, BMJ.

[35]  F. Moll,et al.  Age and coumarin-type anticoagulation are associated with the occurrence of intraplaque hemorrhage, while statins are associated less with intraplaque hemorrhage: a large histopathological study in carotid and femoral plaques. , 2011, Atherosclerosis.

[36]  P. Rothwell,et al.  Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study. European Carotid Surgery Trialists' Collaborative Group. , 1999, Lancet.

[37]  Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. , 1995, JAMA.